Fierce Pharma

NOVEMBER 14, 2023

Earlier this month, Pfizer’s $3.5 billion cost-cutting campaign crossed overseas to Ireland. Now, just a week later, Pfizer is announcing hundreds more job cuts in the U.K. | Pfizer plans to cut approximately 500 roles and ax its Pharmaceutical Sciences Small Molecule capabilities at its site in Sandwich in Kent in the U.K. The move is a consequence of Pfizer’s enterprisewide cost realignment program, which the drugmaker unveiled in mid-October.

Pharmaceutical 348

Pharmaceutical 348

MedCity News

NOVEMBER 14, 2023

Ultimately, to get generative AI in healthcare right we need input from the clinicians who will use these tools – and who understand the ramifications of applying AI without first rigorously testing applications to ensure they are safe and provide clear clinical value.

Patients 125

Patients Healthcare Healthcare 125

Fierce Pharma

NOVEMBER 14, 2023

Johnson & Johnson and Bayer’s wide-spanning VOYAGER PAD study continues to be a gold mine for proving its Xarelto’s worth in several subsets of patients with peripheral artery disease (PAD).

Patients 248

Patients 248

MedCity News

NOVEMBER 14, 2023

Providers must abandon paternalism and treat patients like partners in the decision-making process when drawing up care plans, according to Chris Waugh, Sutter Health’s chief design and innovation officer. Instead of prescribing a major lifestyle overhaul without considering a patient’s unique life circumstances, providers should “recognize that it’s about the tiny things and the accumulation of marginal gains,” he said.

Patients 111

Patients 111

Advertisement

Distribution

Fierce Pharma

NOVEMBER 14, 2023

One study in AstraZeneca’s elaborate R&D plan for lung cancer has reached a dead end. | One study in AstraZeneca’s elaborate R&D plan for lung cancer has reached a dead end. Failure of the Imfinzi-concurrent-chemoradiotherapy regimen deals a blow to AZ’s goal to target more than half of lung cancer patients by 2030.

Patients 211

Patients 211

MedCity News

NOVEMBER 14, 2023

Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.

Leads 105

Leads Pharma Pharmaceutical Patients 105

MedCity News

NOVEMBER 14, 2023

Ovia Health unveiled a new fertility and family-building benefit for employers and health plans that includes financial support, care navigation services and one-on-one concierge support.

103

103

Fierce Pharma

NOVEMBER 14, 2023

In the clinic, Dermavant’s nonsteroidal topical treatment Vtama is progressing nicely as recent trial results have paved the way for it to be approved for atopic dermatitis (eczema) on top of its c | In the clinic, Dermavant’s Vtama is progressing nicely as trial results have paved the way for it to be approved for atopic dermatitis (eczema) on top of its current indication for plaque psoriasis.

Sales 184

Sales Marketing 184

MedCity News

NOVEMBER 14, 2023

Senior care executives have the privilege and responsibility to embrace the profound changes brought about by resident advocacy. We can champion a new era of senior care that puts the individual at the center, honoring their unique identity and aspirations.

96

96

Fierce Pharma

NOVEMBER 14, 2023

An upcoming meeting of the FDA’s oncologic drugs advisory committee is slated to serve as a reminder for cancer drug developers that the agency is keeping a close eye on accelerated approvals. | An upcoming meeting of the FDA’s oncologic drugs advisory committee is slated to serve as a reminder for cancer drug developers that the agency is keeping a close eye on accelerated approvals.

FDA 130

FDA 130

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmExec

NOVEMBER 14, 2023

Novo Nordisk said it will continue providing Levemir vials and the Levemir FlexPen for diabetes control while supplies last, until the full product discontinuation at the end of 2024.

97

97

European Pharmaceutical Review

NOVEMBER 14, 2023

The Association of the British Pharmaceutical Industry (ABPI) has drawn attention to a new report , which has emphasised the importance of UK advanced manufacturing requiring a long-term strategy to ensure its continued success. This ‘manifesto for growth’, developed by the Manufacturing Five (M5), a coalition of the UK’s leading advanced trade associations, proposed the reforms necessary for the UK to close the gap with global competitors and growth of innovative manufacturing in the country.

Manufacturing 94

Manufacturing Pharmaceutical manufacturing Competition Pharmaceutical 94

MedCity News

NOVEMBER 14, 2023

Patient communications platform Artera teamed up with healthcare AI startup Hyro to launch a new chatbot-style assistant for providers’ websites. Using the information already available on the provider’s website, the chatbot can answer patients’ questions 24/7. Some sample questions include “What are the office hours for the radiology department?” and “Where do I park for my visit?

Healthcare 89

Healthcare Healthcare Patients 89

European Pharmaceutical Review

NOVEMBER 14, 2023

Outsourcing regulatory activities in pharma Here, EPR’s Editor explores some key considerations, approaches and strategies for pharmaceutical companies looking to outsource regulatory activities. Accelerating drug development for simple and complex drug programmes Quotient Sciences leverages more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation e

Pharmaceutical 93

Pharmaceutical Pharma 93

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmaTimes

NOVEMBER 14, 2023

The terminal condition currently affects around 5,000 people in the UK - News - PharmaTimes

110

110

European Pharmaceutical Review

NOVEMBER 14, 2023

Ajinomoto Co., Inc. is set to acquire Forge Biologics, a viral vector and plasmid contract development and manufacturing organisation (CDMO) and clinical-stage therapeutics company. According to Forge Biologics, the acquisition is an all-cash deal for $620 million, which is Forge’s enterprise value on a cash-free and debt-free basis. The equity value attributable to unitholders of Forge Biologics is approximately $554 million.

Manufacturing 91

Manufacturing Consulting Pharma Medicine 91

PharmaTimes

NOVEMBER 14, 2023

The projects will explore early-stage ideas at the frontiers of bioscience - News - PharmaTimes

106

106

pharmaphorum

NOVEMBER 14, 2023

AZ’s oncology hopes dented as Imfinzi flunks NSCLC trial Phil.

96

96

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaVoice

NOVEMBER 14, 2023

Johnson & Johnson Innovative Medicine’s director of diversity, equity and inclusion in clinical trials shares key strategies for making DEI work.

Medicine 59

Medicine 59

pharmaphorum

NOVEMBER 14, 2023

AHA: First data backs AskBio’s heart failure gene therapy Phil.

89

89

PharmaTech

NOVEMBER 14, 2023

Dr Seán McMahon explains how Ashland’s Viatel™ bioresorbable work and rationalizes why formulators should consider using in the development of long acting injectables and implants.

52

52

Pharmaceutical Commerce

NOVEMBER 14, 2023

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

Biopharma 52

Biopharma 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Pharmaceutical Technology

NOVEMBER 14, 2023

Concerns have been raised over the suitability of current FDA-approved treatments for myelofibrosis, due to the negative associations with anaemia.

FDA 59

FDA 59

Rep-Lite

NOVEMBER 14, 2023

Success in medical sales requires resilience, adaptability, and the ability to build lasting relationships with healthcare professionals. It’s a competitive field, but for those who excel, it can be a fulfilling and financially rewarding career with uncapped commission bonus opportunities. In this blog post, we’ll look at everything you need to know about medical sales jobs.

Medical sales 52

Medical sales Medical Sales Medical sales reps 52

PharmaTech

NOVEMBER 14, 2023

The eBook discusses how to expedite the development pathway for early phase compounds, and how lipid based formulations provide innovative approach to enhance bioavailability for challenging molecules. It also presents how the lipid-based delivery provides a tool for highly potent, poorly soluble, and unstable APIs.

52

52

PharmExec

NOVEMBER 14, 2023

The rapid evolvement of precision oncology requires real-world data generated at a scale that unlocks insights that can not be provided from clinical trial evidence. Custom integrated real-world evidence solutions like large language models can be used to quickly identify information to make informed decisions.

52

52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Evolve Your Success

NOVEMBER 14, 2023

There is no one way when it comes to medical sales. It is ripe with opportunities along with a variety of paths. One of those is sports medicine. How do you break into this field as a medical sales representative and succeed? As we celebrate International Men’s Day, Samuel Adeyinka interviews Jordan Rawlins about the world of orthopedics, namely sports medicine.

Medical sales 52

Medical sales Medicine Medical Sales 52

Spotio

NOVEMBER 14, 2023

Artificial intelligence (AI) has taken the world by storm. Professionals in a wide array of industries now use this impressive technology to organize complex data points, write text, generate visual artwork, and much more. Good news: You can also use AI to supercharge your sales career! Once you do, you’ll become more productive, make better decisions, and create better customer experiences.

Sales 52

Sales Prospecting Sales pitches Sales process 52

PharmaTech

NOVEMBER 14, 2023

A discussion with Thomas Langenickel, MD, chief medical officer at Ethris, shines a light on how advances made with mRNA technology are also advancing the industry’s ability to focus on treatment of rare diseases, such as rare lung diseases.

Medical 52

Medical 52

Penrod

NOVEMBER 14, 2023

As a marketing services provider , email is incredibly important to our client’s business – and the implications of this ruling are massive. The ruling extends beyond marketing emails, encompassing all operational and commercial emails from a domain. This includes individual employee interactions, meaning large organizations with numerous employees and extensive email marketing capabilities will rapidly reach the threshold.

Marketing 52

Marketing Leads 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management